Celleste Bio
PrivateLast Round
Seed
Dec 5, 2024
Total Funding Raised
$4.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Celleste Bio operates in Energy & Sustainability and is based in Tel Aviv. Its latest recorded funding round was a Seed round in December 2024.
Celleste Bio is a biotechnology company that produces cell-cultured cocoa ingredients, including cocoa butter and powder, as a sustainable alternative to traditional cocoa farming.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celleste Bio Comparables
Compare Celleste Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| California Cultured | 89% | |
| Seminal Biosciences | 88% | |
| Food Brewer | 84% |
For institutional investors. Book with your work email.
Celleste Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2024 | ||||
| Seed | Nov 7, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Celleste Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Regba Agriculture | Seed |
| Supply Change Capital | Seed |
| Consensus Business Group | Seed |
| The Trendlines Group | Seed |
| Consensus Business Group | Seed |
| Barrel Ventures | Seed |
| SnackFutures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 61% MoM.
- Apr 17, 2026
Partnered with Mondelez International for cultured cocoa butter chocolate samples.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
Celleste Bio reaches $84.6M in revenue in 2025.
For institutional investors. Book with your work email.
Celleste Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celleste Bio's valuation, stock price, and market status.
Is Celleste Bio a public or private company?
Celleste Bio is a private company.
What is the current stock price of Celleste Bio?
Celleste Bio is a private company, so its shares have no public market price. Caplight tracks Celleste Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celleste Bio worth (valuation)?
Valuation information for Celleste Bio is not publicly available.
Can I buy Celleste Bio stock?
Celleste Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celleste Bio's last funding round?
Celleste Bio's most recent funding round was Seed on December 5, 2024.
Who are the main investors in Celleste Bio?
Key investors in Celleste Bio include Supply Change Capital.
Will Celleste Bio IPO soon?
No public IPO plans have been announced for Celleste Bio.
How can I track Celleste Bio secondary market activity?
Caplight tracks bids, offers, and trades in Celleste Bio's shares on secondary markets.